Measuring quality of life in patients with myeloma
Evidence & Practice Previous     Next

Measuring quality of life in patients with myeloma

Tanya Burton Myeloma clinical nurse specialist, Heath Hospital, Cardiff
Charlotte Bloodworth Haematology clinical nurse specialist, Heath Hospital, Cardiff

Myeloma is a potentially debilitating and life-limiting haematological cancer and maintaining quality of life (QOL) for people with this disease is important. As survival rates improve, measuring QOL will become more important in myeloma care. This article reports on a project and audit that involved measuring the QOL of patients with myeloma in an outpatient clinic in a single centre in Cardiff. The project and audit raised three main issues: measuring QOL is difficult due to its individualised nature; the tools available to measure QOL in myeloma are designed for use in clinical trials and are not easily transferable to a clinical setting; and the act of measuring QOL is just as important for patients and healthcare professionals as the results. The project has resulted in the development of a dedicated, nurse-led QOL clinic, which will be audited in future.

Cancer Nursing Practice. 15, 8, 32-36. doi: 10.7748/cnp.2016.e1342

Correspondence

charlotte.bloodworth@wales.nhs.uk

Peer review

This article has been subjectto external double-blind peer review and checked for plagiarism using automated software

Conflict of interest

None declared

Received: 27 July 2016

Accepted: 14 September 2016

Want to read more?

Subscribe for unlimited access

Try 1 month’s access for just £1 and get:

Your subscription package includes:
  • Full access to the website and the online archive
  • Bi-monthly digital edition
  • RCNi Portfolio and interactive CPD quizzes
  • RCNi Learning with 200+ evidence-based modules
  • 10 articles a month from any other RCNi journal
Subscribe
Already subscribed? Log in

Alternatively, you can purchase access to this article for the next seven days. Buy now

Or